Literature DB >> 9554326

ADHD through the life span: the role of bupropion in treatment.

D P Cantwell1.   

Abstract

Attention-deficit/hyperactivity disorder (ADHD) is a common problem that begins early in life and in many cases persists through the life span. Psychostimulants have been the psychopharmacologic treatment of choice. Not all patients respond to psychostimulants, and some patients have significant side effects. This paper reviews the use of a nonstimulant psychopharmacologic agent, bupropion, to treat ADHD in both children and adults.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9554326

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  6 in total

1.  Foreword. A comprehensive review of bupropion.

Authors:  Malcolm Lader
Journal:  Clin Drug Investig       Date:  2011-10-19       Impact factor: 2.859

Review 2.  The Black Book of Psychotropic Dosing and Monitoring.

Authors:  Alan F Schatzberg; DeBattista Charles
Journal:  Psychopharmacol Bull       Date:  2018-01-15

Review 3.  Effective treatment for mental disorders in children and adolescents.

Authors:  B J Burns; K Hoagwood; P J Mrazek
Journal:  Clin Child Fam Psychol Rev       Date:  1999-12

4.  The Diagnosis and Management of Attention-Deficit/Hyperactivity Disorder in Pediatric Patients.

Authors:  Andrew R. Adesman
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2001-04

5.  Preparation, Optimization, and Screening of the Effect of Processing Variables on Agar Nanospheres Loaded with Bupropion HCl by a D-Optimal Design.

Authors:  Jaleh Varshosaz; Mohammad Reza Zaki; Mohsen Minaiyan; Jaafar Banoozadeh
Journal:  Biomed Res Int       Date:  2015-05-19       Impact factor: 3.411

6.  Dopamine signaling in C. elegans is mediated in part by HLH-17-dependent regulation of extracellular dopamine levels.

Authors:  Chaquettea M Felton; Casonya M Johnson
Journal:  G3 (Bethesda)       Date:  2014-04-07       Impact factor: 3.154

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.